E. Brambilla
- Oncology top 1%
- Lung Cancer Research Studies 13
- Cancer-related Molecular Pathways 8
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 16
- Lung Cancer Diagnosis and Treatment 14
- Medical Imaging and Pathology Studies 9
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 7
- Microbiology top 2%
- Cancer Research top 2%
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 6
-
- Cell death mechanisms and regulation 4
E. Brambilla
56 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 2.2k
- Pulmonary and Respiratory Medicine 2.7k
- Microbiology 41
- Cancer Research 668
- Epidemiology 977
Countries citing papers authored by E. Brambilla
This map shows the geographic impact of E. Brambilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Brambilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Brambilla more than expected).
Fields of papers citing papers by E. Brambilla
This network shows the impact of papers produced by E. Brambilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Brambilla. The network helps show where E. Brambilla may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Brambilla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive Summarybreakdown → | 2011 | 475 |
| 2 | 2009 | 27 | |
| 3 | 2008 | 46 | |
| 4 | 2008 | 171 | |
| 5 | 2008 | 4 | |
| 6 | 2007 | 72 | |
| 7 | 2007 | 55 | |
| 8 | 2004 | 26 | |
| 9 | 2002 | 120 | |
| 10 | 2002 | 292 | |
| 11 | 2002 | 43 | |
| 12 | The new World Health Organization classification of lung tumoursbreakdown → | 2001 | 864 |
| 13 | 1999 | 152 | |
| 14 | 1997 | 4 | |
| 15 | 1997 | 22 | |
| 16 | 1996 | 15 | |
| 17 | 1996 | 8 | |
| 18 | 1995 | 39 | |
| 19 | 1994 | 153 | |
| 20 | [Extrinsic allergic alveolitis in children. Apropos of 4 cases]. | 1984 | 0 |
About E. Brambilla
E. Brambilla is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Neurology, having authored 59 papers that have together received 5.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (14 papers), Lung Cancer Research Studies (13 papers), Medical Imaging and Pathology Studies (9 papers), Cancer-related Molecular Pathways (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Oncology (2.2k citations), Pulmonary and Respiratory Medicine (2.7k citations), Microbiology (41 citations), Cancer Research (668 citations) and Epidemiology (977 citations). E. Brambilla has collaborated with scholars based in France, United States and Japan. Frequent co-authors include William D. Travis, Yukío Shimosato, B Corrin, T. V. Colby, T V Colby, Christian Brambilla, F Labat-Moleur, Masayuki Noguchi, Mary Beth Beasley and Sylvie Lantuéjoul. Their work appears in journals such as European Respiratory Journal, Lung Cancer, Journal of Clinical Oncology, Clinical Cancer Research and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.